Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data

Abstract Background and objective: The objective of this study was to reach a consensus on the minimum set of data that would allow to optimize the pharmacotherapy follow-up of patients on biologic agents for chronic systemic inflammatory conditions, through structured and standardized collection with an electronic tool in the hospital pharmacy. Materials and method: A scientific committee was formed (n = 5 hospital pharmacists). The Delphi Technique was used, 2 rounds of consultation by e-mail for hospital pharmacists. A structured questionnaire was used, based on a bibliographic review and recommendations by the scientific committee; 37 statements were assessed with the Likert 5-point scale (1= “Strongly Disagree”; 5= “Strongly Agree”). Consensus was reached when 75% or more of panel members assigned a score of 1-2 (rejection consensus) or 4-5 (agreement consensus) to the matter reviewed. Descriptive statistical analyses were conducted. Results: The study included 21 hospital pharmacists (70 were invited, there was 70% response). Consensus was reached for 100% of statements. The minimum set of data was agreed upon, as well as the recommendations that the pharmacist had to collect and make during visits: to document the health status, health-related quality of life, changes in treatment compliance and in patient autonomy, as well as the conditions to make feasible the systematic collection of the minimum data set. Conclusions: There is consensus among hospital pharmacists about a minimum data set to be collected, through an electronic tool, which will order, standardize and structure the pharmacotherapy follow-up of patients with chronic inflammatory conditions on treatment with biologic agents in the Spanish public health system.

Saved in:
Bibliographic Details
Main Authors: Calleja Hernández,Miguel Ángel, Herrero Ambrosio,Alicia, Lamas Díaz,María Jesús, Martínez Cutillas,Julio, Poveda Andrés,José Luis, Aragón,Belén
Format: Digital revista
Language:English
Published: Grupo Aula Médica 2017
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000100031
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1130-63432017000100031
record_format ojs
spelling oai:scielo:S1130-634320170001000312020-10-22Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of dataCalleja Hernández,Miguel ÁngelHerrero Ambrosio,AliciaLamas Díaz,María JesúsMartínez Cutillas,JulioPoveda Andrés,José LuisAragón,Belén Pharmacotherapy follow-up Hospital pharmacy unit Systemic inflammatory condition Tumour necrosis factor-alpha Consensus Delphi Abstract Background and objective: The objective of this study was to reach a consensus on the minimum set of data that would allow to optimize the pharmacotherapy follow-up of patients on biologic agents for chronic systemic inflammatory conditions, through structured and standardized collection with an electronic tool in the hospital pharmacy. Materials and method: A scientific committee was formed (n = 5 hospital pharmacists). The Delphi Technique was used, 2 rounds of consultation by e-mail for hospital pharmacists. A structured questionnaire was used, based on a bibliographic review and recommendations by the scientific committee; 37 statements were assessed with the Likert 5-point scale (1= “Strongly Disagree”; 5= “Strongly Agree”). Consensus was reached when 75% or more of panel members assigned a score of 1-2 (rejection consensus) or 4-5 (agreement consensus) to the matter reviewed. Descriptive statistical analyses were conducted. Results: The study included 21 hospital pharmacists (70 were invited, there was 70% response). Consensus was reached for 100% of statements. The minimum set of data was agreed upon, as well as the recommendations that the pharmacist had to collect and make during visits: to document the health status, health-related quality of life, changes in treatment compliance and in patient autonomy, as well as the conditions to make feasible the systematic collection of the minimum data set. Conclusions: There is consensus among hospital pharmacists about a minimum data set to be collected, through an electronic tool, which will order, standardize and structure the pharmacotherapy follow-up of patients with chronic inflammatory conditions on treatment with biologic agents in the Spanish public health system.Grupo Aula MédicaFarmacia Hospitalaria v.41 n.1 20172017-02-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000100031en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Calleja Hernández,Miguel Ángel
Herrero Ambrosio,Alicia
Lamas Díaz,María Jesús
Martínez Cutillas,Julio
Poveda Andrés,José Luis
Aragón,Belén
spellingShingle Calleja Hernández,Miguel Ángel
Herrero Ambrosio,Alicia
Lamas Díaz,María Jesús
Martínez Cutillas,Julio
Poveda Andrés,José Luis
Aragón,Belén
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data
author_facet Calleja Hernández,Miguel Ángel
Herrero Ambrosio,Alicia
Lamas Díaz,María Jesús
Martínez Cutillas,Julio
Poveda Andrés,José Luis
Aragón,Belén
author_sort Calleja Hernández,Miguel Ángel
title Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data
title_short Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data
title_full Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data
title_fullStr Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data
title_full_unstemmed Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data
title_sort pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the tandardized collection of a minimum set of data
description Abstract Background and objective: The objective of this study was to reach a consensus on the minimum set of data that would allow to optimize the pharmacotherapy follow-up of patients on biologic agents for chronic systemic inflammatory conditions, through structured and standardized collection with an electronic tool in the hospital pharmacy. Materials and method: A scientific committee was formed (n = 5 hospital pharmacists). The Delphi Technique was used, 2 rounds of consultation by e-mail for hospital pharmacists. A structured questionnaire was used, based on a bibliographic review and recommendations by the scientific committee; 37 statements were assessed with the Likert 5-point scale (1= “Strongly Disagree”; 5= “Strongly Agree”). Consensus was reached when 75% or more of panel members assigned a score of 1-2 (rejection consensus) or 4-5 (agreement consensus) to the matter reviewed. Descriptive statistical analyses were conducted. Results: The study included 21 hospital pharmacists (70 were invited, there was 70% response). Consensus was reached for 100% of statements. The minimum set of data was agreed upon, as well as the recommendations that the pharmacist had to collect and make during visits: to document the health status, health-related quality of life, changes in treatment compliance and in patient autonomy, as well as the conditions to make feasible the systematic collection of the minimum data set. Conclusions: There is consensus among hospital pharmacists about a minimum data set to be collected, through an electronic tool, which will order, standardize and structure the pharmacotherapy follow-up of patients with chronic inflammatory conditions on treatment with biologic agents in the Spanish public health system.
publisher Grupo Aula Médica
publishDate 2017
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000100031
work_keys_str_mv AT callejahernandezmiguelangel pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata
AT herreroambrosioalicia pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata
AT lamasdiazmariajesus pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata
AT martinezcutillasjulio pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata
AT povedaandresjoseluis pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata
AT aragonbelen pharmacotherapyfollowupofpatientsundertreatmentwithbiologicagentsforchronicinflammatorysystemicconditionsanagreementamonghospitalpharmacistsforthetandardizedcollectionofaminimumsetofdata
_version_ 1755939079411728384